<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://www.pharmtech.com/pharmtech/servlet/pharmtech_full.rss">
    <title>Pharmaceutical Technology Magazine</title>

    <link>http://www.pharmtech.com/pharmtech</link>

    <description>A publication providing practical information on pharmaceutical manufacturing. Content focuses on
    applied R&amp;amp;D technology, process control and computer-integrated manufacturing, biotechnology and technical
    management.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Nichebusters-a-New-Model-for-Drug-Development-Driv/ArticleStandard/Article/detail/813256?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Raising-the-Bar-in-Tablet-Coating-Equipment-and-Pr/ArticleStandard/Article/detail/813265?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Liquid-Nitrogen-Cooling-Systems-Advantageous-for-L/ArticleStandard/Article/detail/813259?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/The-Next-Generation-in-Aseptic-Filling-Equipment/ArticleStandard/Article/detail/813263?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Multivariate-Approaches-for-Powder-Characterizatio/ArticleStandard/Article/detail/813264?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Vaisala---Conduct-Better-Stability-Studies-Reduce-/ArticleStandard/Article/detail/813832?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/AbbVie-and-Galapagos-Extend-GLPG0634-Collaboration/ArticleStandard/Article/detail/813711?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/USP-Offers-Herbal-Medicines-Compendium/ArticleStandard/Article/detail/813817?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Actavis-to-Acquire-Warner-Chilcott/ArticleStandard/Article/detail/813797?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/AstraZeneca-Provides-Update-on-Oncology-Pipeline/ArticleStandard/Article/detail/813708?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Setting-new-Benchmarks-for-Antibody-Analysis/ArticleStandard/Article/detail/813529?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Online+Only/NEW-genderless-connectors-for-innovative-sterile-c/ArticleStandard/Article/detail/813525?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Legislation-to-Protect-Subjects-in-Clinical-Trials/ArticleStandard/Article/detail/813818?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Editor%27s+Picks/May-2013-Editors-Picks-Products-from-Romaco-and-LB/ArticleStandard/Article/detail/812822?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Troubleshooting/Measuring-Tablet-Hardness-A-Primer/ArticleStandard/Article/detail/812820?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/AbbVie-and-Alvine-Will-Collaborate-on-Celiac-Disea/ArticleStandard/Article/detail/813311?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Theravance-and-Elan-Enter-1-Billion-Royalty-Partic/ArticleStandard/Article/detail/813310?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Report-Previews-Future-of-US-Biosimilar-Market/ArticleStandard/Article/detail/813821?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Production+Lines/Experts-at-INTERPHEX-Discuss-Quality-by-Design/ArticleStandard/Article/detail/812819?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Packaging+%26+Labeling/INTERPHEX-Highlights-Serialization/ArticleStandard/Article/detail/812821?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/FDA-Issues-Pharmacoepidemiologic-Safety-Study-Guid/ArticleStandard/Article/detail/813184?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Biotage-Responds-to-CEM-Corporation-Patent-Dispute/ArticleStandard/Article/detail/813296?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Lillys-Enzastaurin-Disappoints-in-Phase-III-Trial/ArticleStandard/Article/detail/812961?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Online+Only/Amgen-Forms-New-Joint-Venture-to-Commercialize-Vec/ArticleStandard/Article/detail/812960?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/USP-Launches-Initiative-to-Fight-Counterfeit-Drugs/ArticleStandard/Article/detail/813066?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Takeda-to-Acquire-Inviragen-for-up-to-250-Million/ArticleStandard/Article/detail/812838?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/GSK-Announces-Plans-to-Share-Clinical-Trial-Data/ArticleStandard/Article/detail/812739?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/CEM-Wins-Peptide-Patent-Dispute-with-Biotage/ArticleStandard/Article/detail/812900?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Nexera-X2--X-ceptional-insights/ArticleStandard/Article/detail/812812?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Carbon-14-Bioconjugation-Peptides-and-Antibody-Dru/ArticleStandard/Article/detail/812243?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Roche-Engineer-wins-iPad-at-INTERPHEX/ArticleStandard/Article/detail/812334?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Online+Only/USP-Workshop-Addresses-Moisture-Permeation-Into-Pa/ArticleStandard/Article/detail/812718?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/SCHOTT-Doubles-Production-Capacity-for-Polymer-Syr/ArticleStandard/Article/detail/812719?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Biologics/Improving-the-Economics-of-Monoclonal-Antibody-Sep/ArticleStandard/Article/detail/812242?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/812319?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Technology-Provides-Both-For/ArticleStandard/Article/detail/812254?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Advances-in-Biodegradable-Polymer-Technologies-Fac/ArticleStandard/Article/detail/812241?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Optimizing-the-Selection-of-Mixing-Equipment/ArticleStandard/Article/detail/810952?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/European-Medicines-Agency-Changes-Procedures-for-O/ArticleStandard/Article/detail/812698?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Advances-in-Ion-Exchange-Chromatography-Leading-to/ArticleStandard/Article/detail/812252?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Tamiflu-Leads-Q1-Drug-Sales-Growth/ArticleStandard/Article/detail/812541?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/New-Technique-for-Environmental-Monitoring-in-Clea/ArticleStandard/Article/detail/812253?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Most+Viewed+Articles/Pfizer-Opens-Online-Pharmacy-to-Fight-Counterfeit-/ArticleStandard/Article/detail/812543?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Big-Pharmas-Investment-in-Biologics/ArticleStandard/Article/detail/811803?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Strategic-Partnering-for-Manufacturing/ArticleStandard/Article/detail/811818?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Most+Viewed+Articles/The-New-Normal-In-Biotech-Financing/ArticleStandard/Article/detail/811804?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Pharma-News-in-Global-Health-and-Sustainability/ArticleStandard/Article/detail/811821?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/CSR/Pharma-Industry-Participates-in-Vaccine-Initiative/ArticleStandard/Article/detail/811822?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/812317?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Lyophilization-A-Primer/ArticleStandard/Article/detail/813407?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Ingredients+Insider/Intellectual-Property-Battles-in-Solid-State-Chemi/ArticleStandard/Article/detail/813405?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Facility-Trends-Modularization-and-Single-Use/ArticleStandard/Article/detail/813398?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Enhancing-Particle-Size-Measurement-Using-Dry-Lase/ArticleStandard/Article/detail/813408?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/Outsourcings-Modest-Role-as-a-Cost-Containment-Str/ArticleStandard/Article/detail/813399?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/BioForum/ZFN-Technology-Advances-Biopharmaceutical-Manufact/ArticleStandard/Article/detail/813410?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/From+the+Editor/Pathway-to-Publication/ArticleStandard/Article/detail/813394?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Regulatory+Corner/Should-Regulation-of-Combination-Products-Become-M/ArticleStandard/Article/detail/813403?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Understanding-ICH-Q11mdashFDAs-Guidance-on-the-Dev/ArticleStandard/Article/detail/813396?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/FDA-Expectations-for-Supplier-Management/ArticleStandard/Article/detail/813401?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Prefilled-Syringes-or-Peptide-Pills/ArticleStandard/Article/detail/813404?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Ingredients/Using-Thermal-Ink-Jet-Printing-Technology-to-Produ/ArticleStandard/Article/detail/813397?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Statistical+Solutions/Compositing-Samples-and-the-Risk-to-Product-Qualit/ArticleStandard/Article/detail/813392?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Industry+Leaders/QampA-with-Stuart-E-Needleman-Aptuit/ArticleStandard/Article/detail/813406?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Troubleshooting/Using-a-Gravimetric-Feeder-to-Dose-Pharmaceutical-/ArticleStandard/Article/detail/813395?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Ingredients/Academic-and-Public-Partnerships-in-Solid-State-Ch/ArticleStandard/Article/detail/813400?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Convergence-Sought-for-Global-Pharma-Ma/ArticleStandard/Article/detail/813412?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Co-Opetition-in-Drug-Development/ArticleStandard/Article/detail/813391?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Roundup/ArticleStandard/Article/detail/813487?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Standards+%26+Regulation/Report-from-Brazil/ArticleStandard/Article/detail/813393?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/NEW-genderless-connectors-for-innovative-sterile-c/ArticleStandard/Article/detail/812264?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/New-First-to-File-Patent-Rule-Threatens-Open-Colla/ArticleStandard/Article/detail/813409?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Controlling-Ice-Nucleation-During-the-Freezing-Ste/ArticleStandard/Article/detail/813411?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Industry+Insider/Campaign-Against-Counterfeit-Drugs-Continues/ArticleStandard/Article/detail/813491?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/In+the+Spotlight/Product-Spotlight-AutomationITProcess-Control/ArticleStandard/Article/detail/813402?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Pharmaco-Kinesis-Corporation-Develops-First-Nanodr/ArticleStandard/Article/detail/812032?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Delivering-Complex-Drugs-With-Nanotechnology-Based/ArticleStandard/Article/detail/812591?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Whitepapers/OPC-The-Ins-and-Outs-to-What-Its-About/ArticleStandard/Article/detail/812058?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Actemra-Receives-FDA-Approval-for-Polyarticular-Ju/ArticleStandard/Article/detail/812031?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Risk-Mitigation-and-Microbial-Control-and-Monitori/ArticleStandard/Article/detail/812584?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Big-Pharmas-Manufacturing-Investments-in-Biologics/ArticleStandard/Article/detail/812582?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Applying-Continuous-Flow-Pasteurization-and-Steril/ArticleStandard/Article/detail/812590?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Drug+Delivery/Advancing-Drug-Delivery-for-Parenteral-Application/ArticleStandard/Article/detail/812592?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/An-Integrated-Prefilled-Syringe-Platform-Approach-/ArticleStandard/Article/detail/812737?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Feature+Articles/Containment-Verification-Testing-For-Pharmaceutica/ArticleStandard/Article/detail/812735?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Online+Only/PerkinElmer-Announces-Collaboration-with-Chinas-Na/ArticleStandard/Article/detail/811913?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Whitepapers/Protein-Separation-with-pH-Gradients-Using-Composi/ArticleStandard/Article/detail/811991?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/Malvern-Instruments-and-Netzsch-Grinding-amp-Dispe/ArticleStandard/Article/detail/811914?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Bayer-to-Acquire-Conceptus-for-US11-Billion/ArticleStandard/Article/detail/812030?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/Uhlmann-Group-Spins-Off-visiotec-GmbH/ArticleStandard/Article/detail/811915?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Matrikon---OPC-The-Ins-and-Outs-to-What-Its-About/ArticleStandard/Article/detail/811823?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Metrics---USING-QUALITY-BY-DESIGN-TO-IMPROVE-STREN/ArticleStandard/Article/detail/811688?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Catalent-Biologics-Opens-New-Single-Use-Biomanufac/ArticleStandard/Article/detail/811649?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/News/Pharmaceutical-Technology-and-DampB-Launch-Busines/ArticleStandard/Article/detail/811687?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Analytics/Is-My-Method-Still-Valid/ArticleStandard/Article/detail/811595?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Manufacturing+Whitepaper/Impact-of-a-Customized-MALDI-TOF-Library-for-Micro/ArticleStandard/Article/detail/811596?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Standards+%26+Regulation/Establishing-a-Culture-of-Quality/ArticleStandard/Article/detail/811594?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Biological-Storage-Facility/ArticleStandard/Article/detail/811196?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Waters-Purification-Solutions/ArticleStandard/Article/detail/811198?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/Vetter-Development-Service-Filling-your-clinical-d/ArticleStandard/Article/detail/811190?ref=25" />

        <rdf:li
        resource="http://www.pharmtech.com/pharmtech/The-Daikyo-Crystal-Zenith-Insert-Needle-Syringe-Sy/ArticleStandard/Article/detail/811197?ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2013-05-22T02:29:50Z</dc:date>
  </channel>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Nichebusters-a-New-Model-for-Drug-Development-Driv/ArticleStandard/Article/detail/813256?ref=25">

    <title>Nichebusters, a New Model for Drug Development, Drives Use of Modular Biopharmaceutical Facilities</title>

    <link>
    http://www.pharmtech.com/pharmtech/Nichebusters-a-New-Model-for-Drug-Development-Driv/ArticleStandard/Article/detail/813256?ref=25</link>

    <description>The growing demand for targeted biopharmaceutical therapies is driving interest in modular production
    facilities that can be rapidly constructed while still minimizing risk and cost.</description>

    <dc:date>2013-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813256null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Raising-the-Bar-in-Tablet-Coating-Equipment-and-Pr/ArticleStandard/Article/detail/813265?ref=25">

    <title>Raising the Bar in Tablet Coating Equipment and Processing</title>

    <link>
    http://www.pharmtech.com/pharmtech/Raising-the-Bar-in-Tablet-Coating-Equipment-and-Pr/ArticleStandard/Article/detail/813265?ref=25</link>

    <description>Greater automation and the adoption of solid versus perforated pans are some recent
    advances.</description>

    <dc:date>2013-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813265null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Liquid-Nitrogen-Cooling-Systems-Advantageous-for-L/ArticleStandard/Article/detail/813259?ref=25">

    <title>Liquid Nitrogen Cooling Systems Advantageous for Low-Temperature Chemical Synthesis</title>

    <link>
    http://www.pharmtech.com/pharmtech/Liquid-Nitrogen-Cooling-Systems-Advantageous-for-L/ArticleStandard/Article/detail/813259?ref=25</link>

    <description>Access to extremely low and consistently controlled reaction temperatures can improve product yields
    and selectivities while also reducing costs.</description>

    <dc:date>2013-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813259null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/The-Next-Generation-in-Aseptic-Filling-Equipment/ArticleStandard/Article/detail/813263?ref=25">

    <title>The Next Generation in Aseptic-Filling Equipment</title>

    <link>
    http://www.pharmtech.com/pharmtech/The-Next-Generation-in-Aseptic-Filling-Equipment/ArticleStandard/Article/detail/813263?ref=25</link>

    <description>Adoption of single-use systems and more flexible systems drive innovation.</description>

    <dc:date>2013-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813263null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Multivariate-Approaches-for-Powder-Characterizatio/ArticleStandard/Article/detail/813264?ref=25">

    <title>Multivariate Approaches for Powder Characterization</title>

    <link>
    http://www.pharmtech.com/pharmtech/Multivariate-Approaches-for-Powder-Characterizatio/ArticleStandard/Article/detail/813264?ref=25</link>

    <description>Dynamic testing and advances in shear testing provide better insight into powder physical properties
    and external variables that affect powder behavior.</description>

    <dc:date>2013-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813264null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Vaisala---Conduct-Better-Stability-Studies-Reduce-/ArticleStandard/Article/detail/813832?ref=25">

    <title>Vaisala - Conduct Better Stability Studies: Reduce the Risk of Incomplete Records</title>

    <link>
    http://www.pharmtech.com/pharmtech/Vaisala---Conduct-Better-Stability-Studies-Reduce-/ArticleStandard/Article/detail/813832?ref=25</link>

    <description>Vaisala - Conduct Better Stability Studies: Reduce the Risk of Incomplete Records</description>

    <dc:date>2013-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813832null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/AbbVie-and-Galapagos-Extend-GLPG0634-Collaboration/ArticleStandard/Article/detail/813711?ref=25">

    <title>AbbVie and Galapagos Extend GLPG0634 Collaboration</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/AbbVie-and-Galapagos-Extend-GLPG0634-Collaboration/ArticleStandard/Article/detail/813711?ref=25</link>

    <description>AbbVie and Galapagos have extended their collaboration on the clinical development of GLPG0634 to
    include Crohn's disease.</description>

    <dc:date>2013-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813711null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/USP-Offers-Herbal-Medicines-Compendium/ArticleStandard/Article/detail/813817?ref=25">

    <title>USP Offers Herbal Medicines Compendium</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/USP-Offers-Herbal-Medicines-Compendium/ArticleStandard/Article/detail/813817?ref=25</link>

    <description>The U.S. Pharmacopeial Convention is offering free online access to public standards to help ensure
    the quality of the herbal ingredients used in medicinal products.</description>

    <dc:date>2013-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813817null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Actavis-to-Acquire-Warner-Chilcott/ArticleStandard/Article/detail/813797?ref=25">

    <title>Actavis to Acquire Warner Chilcott</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Actavis-to-Acquire-Warner-Chilcott/ArticleStandard/Article/detail/813797?ref=25</link>

    <description>Actavis Inc. and Warner Chilcott plc have entered into a definitive agreement under which Actavis will
    acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion.</description>

    <dc:date>2013-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813797null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/AstraZeneca-Provides-Update-on-Oncology-Pipeline/ArticleStandard/Article/detail/813708?ref=25">

    <title>AstraZeneca Provides Update on Oncology Pipeline</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/AstraZeneca-Provides-Update-on-Oncology-Pipeline/ArticleStandard/Article/detail/813708?ref=25</link>

    <description>AstraZeneca announced that three of its cancer compounds&amp;amp;mdash;moxetumomab pasudotox, olaparib
    and selumetinib&amp;amp;mdash;will be moving forward to Phase III clinical development. Oncology is one of the
    company's core therapy areas and accelerating the development of a number of new molecular entities in its pipeline
    is a strategic priority.</description>

    <dc:date>2013-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813708null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Setting-new-Benchmarks-for-Antibody-Analysis/ArticleStandard/Article/detail/813529?ref=25">

    <title>Setting new Benchmarks for Antibody Analysis</title>

    <link>
    http://www.pharmtech.com/pharmtech/Setting-new-Benchmarks-for-Antibody-Analysis/ArticleStandard/Article/detail/813529?ref=25</link>

    <description>Tosoh Bioscience expands the renowned TSKgel SW series of aqueous size exclusion HPLC columns by three
    new UHPLC columns, tailored to different aspects of antibody analysis.</description>

    <dc:date>2013-05-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813529null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Online+Only/NEW-genderless-connectors-for-innovative-sterile-c/ArticleStandard/Article/detail/813525?ref=25">

    <title>NEW genderless connectors &amp;amp;mdash; for innovative sterile connections</title>

    <link>
    http://www.pharmtech.com/pharmtech/Online+Only/NEW-genderless-connectors-for-innovative-sterile-c/ArticleStandard/Article/detail/813525?ref=25</link>

    <description>Colder?s new genderless AseptiQuik&amp;amp;reg; G Connectors make single-use sterile connections
    faster, easier and safer?even in non-sterile conditions. Universal mating simplifies systems integration, increases
    process flexibility and minimizes operator error.</description>

    <dc:date>2013-05-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813525null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Legislation-to-Protect-Subjects-in-Clinical-Trials/ArticleStandard/Article/detail/813818?ref=25">

    <title>Legislation to Protect Subjects in Clinical Trials Introduced</title>

    <link>
    http://www.pharmtech.com/pharmtech/Legislation-to-Protect-Subjects-in-Clinical-Trials/ArticleStandard/Article/detail/813818?ref=25</link>

    <description>Legislation designed to protect clinical trial study participants, close loopholes, and bring
    certainty and public transparency to research studies, has been introduced.</description>

    <dc:date>2013-05-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813818null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Editor%27s+Picks/May-2013-Editors-Picks-Products-from-Romaco-and-LB/ArticleStandard/Article/detail/812822?ref=25">

    <title>May 2013 Editor's Picks: Products from Romaco and L.B. Bohle</title>

    <link>
    http://www.pharmtech.com/pharmtech/Editor%27s+Picks/May-2013-Editors-Picks-Products-from-Romaco-and-LB/ArticleStandard/Article/detail/812822?ref=25</link>

    <description>Products from Romaco and L.B. Bohle.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812822null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Troubleshooting/Measuring-Tablet-Hardness-A-Primer/ArticleStandard/Article/detail/812820?ref=25">

    <title>Measuring Tablet Hardness: A Primer</title>

    <link>
    http://www.pharmtech.com/pharmtech/Troubleshooting/Measuring-Tablet-Hardness-A-Primer/ArticleStandard/Article/detail/812820?ref=25</link>

    <description>Crushing, fracturing, and bending tests quantify hardness.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812820null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/AbbVie-and-Alvine-Will-Collaborate-on-Celiac-Disea/ArticleStandard/Article/detail/813311?ref=25">

    <title>AbbVie and Alvine Will Collaborate on Celiac Disease Therapy</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/AbbVie-and-Alvine-Will-Collaborate-on-Celiac-Disea/ArticleStandard/Article/detail/813311?ref=25</link>

    <description>Program aims to develop a novel oral treatment.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813311null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Theravance-and-Elan-Enter-1-Billion-Royalty-Partic/ArticleStandard/Article/detail/813310?ref=25">

    <title>Theravance and Elan Enter $1 Billion Royalty Participation Agreement</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Theravance-and-Elan-Enter-1-Billion-Royalty-Partic/ArticleStandard/Article/detail/813310?ref=25</link>

    <description>Elan will purchase interest in four respiratory programs.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813310null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Report-Previews-Future-of-US-Biosimilar-Market/ArticleStandard/Article/detail/813821?ref=25">

    <title>Report Previews Future of U.S. Biosimilar Market</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Report-Previews-Future-of-US-Biosimilar-Market/ArticleStandard/Article/detail/813821?ref=25</link>

    <description>Thomson Reuters released a report that provides a view of the challenges facing companies entering the
    United States biosimilar drug market.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/212013/813821null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Production+Lines/Experts-at-INTERPHEX-Discuss-Quality-by-Design/ArticleStandard/Article/detail/812819?ref=25">

    <title>Experts at INTERPHEX Discuss Quality by Design</title>

    <link>
    http://www.pharmtech.com/pharmtech/Production+Lines/Experts-at-INTERPHEX-Discuss-Quality-by-Design/ArticleStandard/Article/detail/812819?ref=25</link>

    <description>Making the effort to apply new methods to pharmaceutical processing will bring benefits.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812819null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Packaging+%26+Labeling/INTERPHEX-Highlights-Serialization/ArticleStandard/Article/detail/812821?ref=25">

    <title>INTERPHEX Highlights Serialization</title>

    <link>
    http://www.pharmtech.com/pharmtech/Packaging+%26+Labeling/INTERPHEX-Highlights-Serialization/ArticleStandard/Article/detail/812821?ref=25</link>

    <description>Integrated serialization systems keep pace with industry demand.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812821null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/FDA-Issues-Pharmacoepidemiologic-Safety-Study-Guid/ArticleStandard/Article/detail/813184?ref=25">

    <title>FDA Issues Pharmacoepidemiologic Safety Study Guidance</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/FDA-Issues-Pharmacoepidemiologic-Safety-Study-Guid/ArticleStandard/Article/detail/813184?ref=25</link>

    <description>FDA has released guidance on best practices for conducting and reporting pharmacoepidemiologic safety
    studies.</description>

    <dc:date>2013-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813184null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Biotage-Responds-to-CEM-Corporation-Patent-Dispute/ArticleStandard/Article/detail/813296?ref=25">

    <title>Biotage Responds to CEM Corporation Patent Dispute</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Biotage-Responds-to-CEM-Corporation-Patent-Dispute/ArticleStandard/Article/detail/813296?ref=25</link>

    <description>Biotage issued a statement in response to a recent announcement from CEM Corporation about a patent
    issue with Biotage.</description>

    <dc:date>2013-05-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813296null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Lillys-Enzastaurin-Disappoints-in-Phase-III-Trial/ArticleStandard/Article/detail/812961?ref=25">

    <title>Lilly's Enzastaurin Disappoints in Phase III Trial</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Lillys-Enzastaurin-Disappoints-in-Phase-III-Trial/ArticleStandard/Article/detail/812961?ref=25</link>

    <description>Eli Lilly reported that enzastaurin did not meet the primary endpoint in a Phase III study, which
    evaluated the agent as a monotherapy for the prevention of relapse in patients with diffuse large B-cell lymphoma
    (DLBCL).</description>

    <dc:date>2013-05-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/812961null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Online+Only/Amgen-Forms-New-Joint-Venture-to-Commercialize-Vec/ArticleStandard/Article/detail/812960?ref=25">

    <title>Amgen Forms New Joint Venture to Commercialize Vectibix in China</title>

    <link>
    http://www.pharmtech.com/pharmtech/Online+Only/Amgen-Forms-New-Joint-Venture-to-Commercialize-Vec/ArticleStandard/Article/detail/812960?ref=25</link>

    <description>Amgen and Zhejiang Beta Pharma have signed an agreement to form a joint venture to commercialize
    Amgen's Vectibix (panitumumab) in the Chinese market. The aim is to quickly and efficiently deliver Vectibix to
    patients in China. Vectibix is a fully human anti-epidermal growth factor receptor (EGFR) antibody approved by FDA
    for the treatment of metastatic colorectal cancer.</description>

    <dc:date>2013-05-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/812960null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/USP-Launches-Initiative-to-Fight-Counterfeit-Drugs/ArticleStandard/Article/detail/813066?ref=25">

    <title>USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/USP-Launches-Initiative-to-Fight-Counterfeit-Drugs/ArticleStandard/Article/detail/813066?ref=25</link>

    <description>New Center for Pharmaceutical Advancement and Training increases number of experts and available tools
    in Sub-Saharan countries.</description>

    <dc:date>2013-05-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813066null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Takeda-to-Acquire-Inviragen-for-up-to-250-Million/ArticleStandard/Article/detail/812838?ref=25">

    <title>Takeda to Acquire Inviragen for up to $250 Million</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Takeda-to-Acquire-Inviragen-for-up-to-250-Million/ArticleStandard/Article/detail/812838?ref=25</link>

    <description>Takeda and US vaccines maker Inviragen jointly announced that they have entered into a definitive
    agreement for Takeda to acquire Inviragen for an upfront payment of US$35 million and future payments of up to
    US$215 million upon achievement of key commercial milestones, linked to the progress of clinical
    development.</description>

    <dc:date>2013-05-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812838null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/GSK-Announces-Plans-to-Share-Clinical-Trial-Data/ArticleStandard/Article/detail/812739?ref=25">

    <title>GSK Announces Plans to Share Clinical Trial Data</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/GSK-Announces-Plans-to-Share-Clinical-Trial-Data/ArticleStandard/Article/detail/812739?ref=25</link>

    <description>In its commitment to transparency, GlaxoSmithKline (GSK) has outlined plans to share detailed data
    from its clinical trials. GSK is to establish a new online system that will enable researchers to request access to
    anonymised patient level data.</description>

    <dc:date>2013-05-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812739null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/CEM-Wins-Peptide-Patent-Dispute-with-Biotage/ArticleStandard/Article/detail/812900?ref=25">

    <title>CEM Wins Peptide Patent Dispute with Biotage</title>

    <link>
    http://www.pharmtech.com/pharmtech/Company+and+People+Notes/CEM-Wins-Peptide-Patent-Dispute-with-Biotage/ArticleStandard/Article/detail/812900?ref=25</link>

    <description>CEM Corp. announced that its European Patent covering microwave assisted solid phase peptide synthesis
    has been upheld.</description>

    <dc:date>2013-05-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812900null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Nexera-X2--X-ceptional-insights/ArticleStandard/Article/detail/812812?ref=25">

    <title>Nexera X2 &amp;amp;#151; X-ceptional insights</title>

    <link>
    http://www.pharmtech.com/pharmtech/Nexera-X2--X-ceptional-insights/ArticleStandard/Article/detail/812812?ref=25</link>

    <description>Ultra-high sensitivity, expanded flexibility, increased stability and robustness - the new Nex-era X2
    UHPLC system targets routine analysis and applications in highly regulated environ-ments demanding complex system
    setups</description>

    <dc:date>2013-05-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812812null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Carbon-14-Bioconjugation-Peptides-and-Antibody-Dru/ArticleStandard/Article/detail/812243?ref=25">

    <title>Carbon-14 Bioconjugation: Peptides and Antibody-Drug Conjugates</title>

    <link>
    http://www.pharmtech.com/pharmtech/Carbon-14-Bioconjugation-Peptides-and-Antibody-Dru/ArticleStandard/Article/detail/812243?ref=25</link>

    <description>The authors explain how the synergy between peptide and protein technology and radiolabeling groups
    can enable the manufacture of carbon-14 labeled peptides and antibody-drug conjugates.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812243null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Roche-Engineer-wins-iPad-at-INTERPHEX/ArticleStandard/Article/detail/812334?ref=25">

    <title>Roche Engineer wins iPad at INTERPHEX</title>

    <link>
    http://www.pharmtech.com/pharmtech/Roche-Engineer-wins-iPad-at-INTERPHEX/ArticleStandard/Article/detail/812334?ref=25</link>

    <description>Roche Engineer wins iPad at INTERPHEX</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812334null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Online+Only/USP-Workshop-Addresses-Moisture-Permeation-Into-Pa/ArticleStandard/Article/detail/812718?ref=25">

    <title>USP Workshop Addresses Moisture Permeation Into Packages</title>

    <link>
    http://www.pharmtech.com/pharmtech/Online+Only/USP-Workshop-Addresses-Moisture-Permeation-Into-Pa/ArticleStandard/Article/detail/812718?ref=25</link>

    <description>The workshop will cover a proposed new method for measuring moisture vapor transmission
    rate.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812718null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/SCHOTT-Doubles-Production-Capacity-for-Polymer-Syr/ArticleStandard/Article/detail/812719?ref=25">

    <title>SCHOTT Doubles Production Capacity for Polymer Syringes</title>

    <link>
    http://www.pharmtech.com/pharmtech/Company+and+People+Notes/SCHOTT-Doubles-Production-Capacity-for-Polymer-Syr/ArticleStandard/Article/detail/812719?ref=25</link>

    <description>New line in Swiss facility produces ready-to-fill syringes.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812719null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Biologics/Improving-the-Economics-of-Monoclonal-Antibody-Sep/ArticleStandard/Article/detail/812242?ref=25">

    <title>Improving the Economics of Monoclonal Antibody Separation</title>

    <link>
    http://www.pharmtech.com/pharmtech/Biologics/Improving-the-Economics-of-Monoclonal-Antibody-Sep/ArticleStandard/Article/detail/812242?ref=25</link>

    <description>Advances in monoclonal antibody separation technologies are largely driven by the need to increase
    efficiencies and reduce cost.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812242null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/812319?ref=25">

    <title>Orally Disintegrating Tablets</title>

    <link>
    http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/812319?ref=25</link>

    <description>Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery
    of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can
    help.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812319null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Technology-Provides-Both-For/ArticleStandard/Article/detail/812254?ref=25">

    <title>Orally Disintegrating Technology Provides Both Formulating Challenges and Opportunities</title>

    <link>
    http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Technology-Provides-Both-For/ArticleStandard/Article/detail/812254?ref=25</link>

    <description>Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery
    of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can
    help.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812254null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Advances-in-Biodegradable-Polymer-Technologies-Fac/ArticleStandard/Article/detail/812241?ref=25">

    <title>Advances in Biodegradable Polymer Technologies Facilitate Sustained Release of Parenteral Drugs</title>

    <link>
    http://www.pharmtech.com/pharmtech/Advances-in-Biodegradable-Polymer-Technologies-Fac/ArticleStandard/Article/detail/812241?ref=25</link>

    <description>New platform technologies and polymer chemistries may facilitate self-administration, longer-term
    delivery, and targeted delivery of parenteral drugs.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812241null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Optimizing-the-Selection-of-Mixing-Equipment/ArticleStandard/Article/detail/810952?ref=25">

    <title>Optimizing the Selection of Mixing Equipment</title>

    <link>
    http://www.pharmtech.com/pharmtech/Optimizing-the-Selection-of-Mixing-Equipment/ArticleStandard/Article/detail/810952?ref=25</link>

    <description>Effective blenders provide efficient, homogeneous mixing and de-aeration for a wide range of
    formulations</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/162013/810952null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/European-Medicines-Agency-Changes-Procedures-for-O/ArticleStandard/Article/detail/812698?ref=25">

    <title>European Medicines Agency Changes Procedures for Orphan Drug Fees</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/European-Medicines-Agency-Changes-Procedures-for-O/ArticleStandard/Article/detail/812698?ref=25</link>

    <description>EMA streamlines orphan drug application procedure.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812698null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Advances-in-Ion-Exchange-Chromatography-Leading-to/ArticleStandard/Article/detail/812252?ref=25">

    <title>Advances in Ion-Exchange Chromatography Leading to Increased Efficiencies and Reduced Costs</title>

    <link>
    http://www.pharmtech.com/pharmtech/Advances-in-Ion-Exchange-Chromatography-Leading-to/ArticleStandard/Article/detail/812252?ref=25</link>

    <description>New ion-exchange chromatography media are more tolerant of varying conditions, making it possible to
    eliminate process steps.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812252null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Tamiflu-Leads-Q1-Drug-Sales-Growth/ArticleStandard/Article/detail/812541?ref=25">

    <title>Tamiflu Leads Q1 Drug Sales Growth</title>

    <link>
    http://www.pharmtech.com/pharmtech/Tamiflu-Leads-Q1-Drug-Sales-Growth/ArticleStandard/Article/detail/812541?ref=25</link>

    <description>In the first quarter of 2013, the rankings for the top five drugs by sales shifted a bit, but
    exhibited positive growth for the quarter.</description>

    <dc:date>2013-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812541null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/New-Technique-for-Environmental-Monitoring-in-Clea/ArticleStandard/Article/detail/812253?ref=25">

    <title>New Technique for Environmental Monitoring in Clean Rooms: Real-Time Viable Particle Counting</title>

    <link>
    http://www.pharmtech.com/pharmtech/New-Technique-for-Environmental-Monitoring-in-Clea/ArticleStandard/Article/detail/812253?ref=25</link>

    <description>TSI's BioTrak Real-Time Viable Particle Counter, provide Quality Assurance professionals with
    additional, valuable information to find root causes of viable and non-viable particle excursions.</description>

    <dc:date>2013-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812253null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Most+Viewed+Articles/Pfizer-Opens-Online-Pharmacy-to-Fight-Counterfeit-/ArticleStandard/Article/detail/812543?ref=25">

    <title>Pfizer Opens Online Pharmacy to Fight Counterfeit Medicine</title>

    <link>
    http://www.pharmtech.com/pharmtech/Most+Viewed+Articles/Pfizer-Opens-Online-Pharmacy-to-Fight-Counterfeit-/ArticleStandard/Article/detail/812543?ref=25</link>

    <description>Pfizer has launched a prescription-fulfillment website for Viagra tablets in an effort to combat the
    online sale of counterfeited medicine.</description>

    <dc:date>2013-05-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812543null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Big-Pharmas-Investment-in-Biologics/ArticleStandard/Article/detail/811803?ref=25">

    <title>Big Pharma's Investment in Biologics</title>

    <link>
    http://www.pharmtech.com/pharmtech/Big-Pharmas-Investment-in-Biologics/ArticleStandard/Article/detail/811803?ref=25</link>

    <description>Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Sanofi, and Roche are among the companies expanding
    biologic-based manufacturing capacity.</description>

    <dc:date>2013-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811803null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Strategic-Partnering-for-Manufacturing/ArticleStandard/Article/detail/811818?ref=25">

    <title>Strategic Partnering for Manufacturing</title>

    <link>
    http://www.pharmtech.com/pharmtech/Strategic-Partnering-for-Manufacturing/ArticleStandard/Article/detail/811818?ref=25</link>

    <description>Eisai and Biogen Idec pursue an innovative approach to capacity management.</description>

    <dc:date>2013-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811818null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Most+Viewed+Articles/The-New-Normal-In-Biotech-Financing/ArticleStandard/Article/detail/811804?ref=25">

    <title>The New Normal in Biotech Financing</title>

    <link>
    http://www.pharmtech.com/pharmtech/Most+Viewed+Articles/The-New-Normal-In-Biotech-Financing/ArticleStandard/Article/detail/811804?ref=25</link>

    <description>Financing to biotech companies in North American and Europe declined in 2012 as debt funding decreased
    and the IPO market remained weak.</description>

    <dc:date>2013-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811804null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Pharma-News-in-Global-Health-and-Sustainability/ArticleStandard/Article/detail/811821?ref=25">

    <title>Pharma News in Global Health and Sustainability</title>

    <link>
    http://www.pharmtech.com/pharmtech/Pharma-News-in-Global-Health-and-Sustainability/ArticleStandard/Article/detail/811821?ref=25</link>

    <description>A roundup of developments in global health and sustainability from the bio/pharmaceutical industry,
    its suppliers, and other public and private organizations.</description>

    <dc:date>2013-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811821null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/CSR/Pharma-Industry-Participates-in-Vaccine-Initiative/ArticleStandard/Article/detail/811822?ref=25">

    <title>Pharma Industry Participates in Vaccine Initiatives</title>

    <link>
    http://www.pharmtech.com/pharmtech/CSR/Pharma-Industry-Participates-in-Vaccine-Initiative/ArticleStandard/Article/detail/811822?ref=25</link>

    <description>The Global Vaccine Action plan maps out a strategy to increase access and R&amp;amp;amp;D for
    vaccines.</description>

    <dc:date>2013-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811822null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/812317?ref=25">

    <title>Orally Disintegrating Tablets</title>

    <link>
    http://www.pharmtech.com/pharmtech/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/812317?ref=25</link>

    <description>Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at
    Catalent Pharma Solutions</description>

    <dc:date>2013-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812317null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Lyophilization-A-Primer/ArticleStandard/Article/detail/813407?ref=25">

    <title>Lyophilization: A Primer</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Lyophilization-A-Primer/ArticleStandard/Article/detail/813407?ref=25</link>

    <description>Optimized freeze-drying cycles can offer scientific and business advantages.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813407/0513_primer_thumb_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813407null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Ingredients+Insider/Intellectual-Property-Battles-in-Solid-State-Chemi/ArticleStandard/Article/detail/813405?ref=25">

    <title>Intellectual Property Battles in Solid-State Chemistry</title>

    <link>
    http://www.pharmtech.com/pharmtech/Ingredients+Insider/Intellectual-Property-Battles-in-Solid-State-Chemi/ArticleStandard/Article/detail/813405?ref=25</link>

    <description>The rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other
    recent case law raise important issues on patent strategies for solid forms.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813405/pt0513_api_thumb_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813405null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Facility-Trends-Modularization-and-Single-Use/ArticleStandard/Article/detail/813398?ref=25">

    <title>Facility Trends: Modularization and Single Use</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Facility-Trends-Modularization-and-Single-Use/ArticleStandard/Article/detail/813398?ref=25</link>

    <description>Pharmaceutical Technology spoke with INTERPHEX 2013 conference-session presenters to gain insight on
    trends in facility and process design.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813398null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Enhancing-Particle-Size-Measurement-Using-Dry-Lase/ArticleStandard/Article/detail/813408?ref=25">

    <title>Enhancing Particle-Size Measurement Using Dry Laser-Diffraction Particle-Size Analysis</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Enhancing-Particle-Size-Measurement-Using-Dry-Lase/ArticleStandard/Article/detail/813408?ref=25</link>

    <description>The author examines dry dispersion and outlines the related analytical method
    development.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813408/pt0513_prmalvern_thumg_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813408null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/Outsourcings-Modest-Role-as-a-Cost-Containment-Str/ArticleStandard/Article/detail/813399?ref=25">

    <title>Outsourcing's Modest Role as a Cost-Containment Strategy</title>

    <link>
    http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/Outsourcings-Modest-Role-as-a-Cost-Containment-Str/ArticleStandard/Article/detail/813399?ref=25</link>

    <description>Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary
    weapon.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813399null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/BioForum/ZFN-Technology-Advances-Biopharmaceutical-Manufact/ArticleStandard/Article/detail/813410?ref=25">

    <title>ZFN Technology Advances Biopharmaceutical Manufacturing</title>

    <link>
    http://www.pharmtech.com/pharmtech/BioForum/ZFN-Technology-Advances-Biopharmaceutical-Manufact/ArticleStandard/Article/detail/813410?ref=25</link>

    <description>Applications of ZFN technology in biopharmaceutical cell-line engineering.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813410null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/From+the+Editor/Pathway-to-Publication/ArticleStandard/Article/detail/813394?ref=25">

    <title>Pathway to Publication</title>

    <link>
    http://www.pharmtech.com/pharmtech/From+the+Editor/Pathway-to-Publication/ArticleStandard/Article/detail/813394?ref=25</link>

    <description>Wanted: Article contributions on drug and process development topics.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813394null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Regulatory+Corner/Should-Regulation-of-Combination-Products-Become-M/ArticleStandard/Article/detail/813403?ref=25">

    <title>Should Regulation of Combination Products Become More Centralized in Europe?</title>

    <link>
    http://www.pharmtech.com/pharmtech/Regulatory+Corner/Should-Regulation-of-Combination-Products-Become-M/ArticleStandard/Article/detail/813403?ref=25</link>

    <description>While there are those who want combination products to be controlled by a centralized
    pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a
    decentralized device-focused approach.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813403null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Understanding-ICH-Q11mdashFDAs-Guidance-on-the-Dev/ArticleStandard/Article/detail/813396?ref=25">

    <title>Understanding ICH Q11&amp;amp;mdash;FDA's Guidance on the Development and Manufacture of Drug
    Substances</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Understanding-ICH-Q11mdashFDAs-Guidance-on-the-Dev/ArticleStandard/Article/detail/813396?ref=25</link>

    <description>The author provides a review of FDA's guidance document, Guidance for Industry: Q11 Development and
    Manufacture of Drug Substances, and its relation to the International Conference on Harmonization's Q11 document
    and its application to the industry.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813396null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/FDA-Expectations-for-Supplier-Management/ArticleStandard/Article/detail/813401?ref=25">

    <title>FDA Expectations for Supplier Management</title>

    <link>
    http://www.pharmtech.com/pharmtech/FDA-Expectations-for-Supplier-Management/ArticleStandard/Article/detail/813401?ref=25</link>

    <description>James Stumpff, Principal Consultant at PAREXEL discusses supplier management and FDA's
    expectations.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813401null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Prefilled-Syringes-or-Peptide-Pills/ArticleStandard/Article/detail/813404?ref=25">

    <title>Prefilled Syringes or Peptide Pills?</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Prefilled-Syringes-or-Peptide-Pills/ArticleStandard/Article/detail/813404?ref=25</link>

    <description>The impact of new delivery technologies in designing peptide therapies.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813404/pt0513_pharm_thumb_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813404null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Ingredients/Using-Thermal-Ink-Jet-Printing-Technology-to-Produ/ArticleStandard/Article/detail/813397?ref=25">

    <title>Using Thermal Ink-Jet Printing Technology to Produce Pharmaceutical Cocrystals</title>

    <link>
    http://www.pharmtech.com/pharmtech/Ingredients/Using-Thermal-Ink-Jet-Printing-Technology-to-Produ/ArticleStandard/Article/detail/813397?ref=25</link>

    <description>Cocrystals are used to improve the performance of APIs that have non-ideal physiochemical properties
    by cocrystallizing the API with a second compound that modulates the API to provide a way to improve a drug's
    bioavailability, stability, and processability.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813397null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Statistical+Solutions/Compositing-Samples-and-the-Risk-to-Product-Qualit/ArticleStandard/Article/detail/813392?ref=25">

    <title>Compositing Samples and the Risk to Product Quality</title>

    <link>
    http://www.pharmtech.com/pharmtech/Statistical+Solutions/Compositing-Samples-and-the-Risk-to-Product-Qualit/ArticleStandard/Article/detail/813392?ref=25</link>

    <description>Compositing samples is appropriate under certain circumstances but raises caveats on how and when it
    should be applied.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813392null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Industry+Leaders/QampA-with-Stuart-E-Needleman-Aptuit/ArticleStandard/Article/detail/813406?ref=25">

    <title>Q&amp;amp;amp;A with Stuart E. Needleman, Aptuit</title>

    <link>
    http://www.pharmtech.com/pharmtech/Industry+Leaders/QampA-with-Stuart-E-Needleman-Aptuit/ArticleStandard/Article/detail/813406?ref=25</link>

    <description>A Q&amp;amp;amp;A with Stuart E. Needleman, President and Chief Operating Officer of Aptuit, on recent
    industry trends.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813406/needleman_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813406null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Troubleshooting/Using-a-Gravimetric-Feeder-to-Dose-Pharmaceutical-/ArticleStandard/Article/detail/813395?ref=25">

    <title>Using a Gravimetric Feeder to Dose Pharmaceutical Bulk Solids</title>

    <link>
    http://www.pharmtech.com/pharmtech/Troubleshooting/Using-a-Gravimetric-Feeder-to-Dose-Pharmaceutical-/ArticleStandard/Article/detail/813395?ref=25</link>

    <description>Loss-in-weight feeders provide high accuracy for batch or continuous processes.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813395null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Ingredients/Academic-and-Public-Partnerships-in-Solid-State-Ch/ArticleStandard/Article/detail/813400?ref=25">

    <title>Academic and Public Partnerships in Solid-State Chemistry</title>

    <link>
    http://www.pharmtech.com/pharmtech/Ingredients/Academic-and-Public-Partnerships-in-Solid-State-Ch/ArticleStandard/Article/detail/813400?ref=25</link>

    <description>Solid-state chemistry is an important part of drug development, and public research is advancing the
    field.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813400null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Convergence-Sought-for-Global-Pharma-Ma/ArticleStandard/Article/detail/813412?ref=25">

    <title>Regulatory Convergence Sought for Global Pharma Market</title>

    <link>
    http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Convergence-Sought-for-Global-Pharma-Ma/ArticleStandard/Article/detail/813412?ref=25</link>

    <description>Manufacturers work with international authorities to harmonize drug registration and supply-chain
    oversight.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813412null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Co-Opetition-in-Drug-Development/ArticleStandard/Article/detail/813391?ref=25">

    <title>Co-Opetition in Drug Development</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Co-Opetition-in-Drug-Development/ArticleStandard/Article/detail/813391?ref=25</link>

    <description>The author suggests co-opetition as a future model for collaboration in drug
    development.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813391null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Roundup/ArticleStandard/Article/detail/813487?ref=25">

    <title>Regulatory Roundup</title>

    <link>
    http://www.pharmtech.com/pharmtech/Regulatory+Corner/Regulatory-Roundup/ArticleStandard/Article/detail/813487?ref=25</link>

    <description>FDA faces budget crunch; Supreme Court hears key cases</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813487null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Standards+%26+Regulation/Report-from-Brazil/ArticleStandard/Article/detail/813393?ref=25">

    <title>Report from Brazil</title>

    <link>
    http://www.pharmtech.com/pharmtech/Standards+%26+Regulation/Report-from-Brazil/ArticleStandard/Article/detail/813393?ref=25</link>

    <description>Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority
    released a study on price-cap control and its benefits in the past years.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813393null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/NEW-genderless-connectors-for-innovative-sterile-c/ArticleStandard/Article/detail/812264?ref=25">

    <title>NEW genderless connectors&amp;amp;reg; for innovative sterile connections</title>

    <link>
    http://www.pharmtech.com/pharmtech/NEW-genderless-connectors-for-innovative-sterile-c/ArticleStandard/Article/detail/812264?ref=25</link>

    <description>Colder?s new genderless AseptiQuik? G Connectors make single-use sterile connections faster, easier
    and safer?even in non-sterile conditions. Universal mating simplifies systems integration, increases process
    flexibility and minimizes operator error.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812264null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/New-First-to-File-Patent-Rule-Threatens-Open-Colla/ArticleStandard/Article/detail/813409?ref=25">

    <title>New First-to-File Patent Rule Threatens Open Collaboration</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/New-First-to-File-Patent-Rule-Threatens-Open-Colla/ArticleStandard/Article/detail/813409?ref=25</link>

    <description>New US patent rules change the playing field for open innovation.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813409null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Controlling-Ice-Nucleation-During-the-Freezing-Ste/ArticleStandard/Article/detail/813411?ref=25">

    <title>Controlling Ice Nucleation During the Freezing Step of Lyophilization</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Controlling-Ice-Nucleation-During-the-Freezing-Ste/ArticleStandard/Article/detail/813411?ref=25</link>

    <description>Lyophilization technologies for controlled nucleation.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813411/pt0513_cvs_thumb_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813411null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Industry+Insider/Campaign-Against-Counterfeit-Drugs-Continues/ArticleStandard/Article/detail/813491?ref=25">

    <title>Campaign Against Counterfeit Drugs Continues</title>

    <link>
    http://www.pharmtech.com/pharmtech/Industry+Insider/Campaign-Against-Counterfeit-Drugs-Continues/ArticleStandard/Article/detail/813491?ref=25</link>

    <description>Drug companies team up with INTERPOL to keep counterfeit medicines off the Internet and out of the
    hands of patients.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813491null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/In+the+Spotlight/Product-Spotlight-AutomationITProcess-Control/ArticleStandard/Article/detail/813402?ref=25">

    <title>Product Spotlight: Automation/IT/Process Control</title>

    <link>
    http://www.pharmtech.com/pharmtech/In+the+Spotlight/Product-Spotlight-AutomationITProcess-Control/ArticleStandard/Article/detail/813402?ref=25</link>

    <description>New product reviews for May 2013, featuring automation, IT, and process control systems.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813402null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Pharmaco-Kinesis-Corporation-Develops-First-Nanodr/ArticleStandard/Article/detail/812032?ref=25">

    <title>Pharmaco-Kinesis Corporation Develops First Nanodrug Combination for Glioma</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Pharmaco-Kinesis-Corporation-Develops-First-Nanodr/ArticleStandard/Article/detail/812032?ref=25</link>

    <description>Pharmaco-Kinesis Corporation (PKC) announced that it is developing the first nanodrug combination of
    Merck's temozolomide and Celgene's thalidomide (in a 50:50 ratio) for the treatment of gliomas and other cancers.
    PKC will collaborate with the University of California, San Diego's department of nano-engineering at the Moores
    cancer centre to develop the nanodroplet formulation.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812032null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Delivering-Complex-Drugs-With-Nanotechnology-Based/ArticleStandard/Article/detail/812591?ref=25">

    <title>Delivering Complex Drugs With Nanotechnology-Based Solutions</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Delivering-Complex-Drugs-With-Nanotechnology-Based/ArticleStandard/Article/detail/812591?ref=25</link>

    <description>Parenteral drug delivery offers a variety of challenges but also opportunities. The author examines
    recent developments in nanotechnology-based drug delivery and other advances in injection-based drug
    delivery.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812591/pts0513_forum_t_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812591null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Whitepapers/OPC-The-Ins-and-Outs-to-What-Its-About/ArticleStandard/Article/detail/812058?ref=25">

    <title>OPC: The Ins and Outs to What It's About</title>

    <link>
    http://www.pharmtech.com/pharmtech/Whitepapers/OPC-The-Ins-and-Outs-to-What-Its-About/ArticleStandard/Article/detail/812058?ref=25</link>

    <description>The Every Man's Guide to OPC is an easy-to-read overview of the most popular industrial open
    connectivity standar - OPC. This paper first introduces the main idea behind OPC, shows why OPC is different from
    conventional (often proprietary) communication protocols, and explains how OPC helps overcome the limitations of
    such native protocols.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812058null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Actemra-Receives-FDA-Approval-for-Polyarticular-Ju/ArticleStandard/Article/detail/812031?ref=25">

    <title>Actemra Receives FDA Approval for Polyarticular Juvenile Idiopathic Arthritis</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Actemra-Receives-FDA-Approval-for-Polyarticular-Ju/ArticleStandard/Article/detail/812031?ref=25</link>

    <description>Genentech announced that FDA has approved Actemra (tocilizumab) for the treatment of polyarticular
    juvenile idiopathic arthritis (PJIA) in children aged two years and older.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812031null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Risk-Mitigation-and-Microbial-Control-and-Monitori/ArticleStandard/Article/detail/812584?ref=25">

    <title>Risk Mitigation and Microbial Control and Monitoring of Cleanrooms</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Risk-Mitigation-and-Microbial-Control-and-Monitori/ArticleStandard/Article/detail/812584?ref=25</link>

    <description>A control strategy can maintain a low level of particulates, and thereby a low bioburden, in
    cleanrooms</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812584null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Big-Pharmas-Manufacturing-Investments-in-Biologics/ArticleStandard/Article/detail/812582?ref=25">

    <title>Big Pharma's Manufacturing Investments in Biologics</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Big-Pharmas-Manufacturing-Investments-in-Biologics/ArticleStandard/Article/detail/812582?ref=25</link>

    <description>Despite overall manufacturing rationalization in the pharmaceutical/biopharmaceutical industry, the
    large pharmaceutical companies continue to invest in biologic-based manufacturing. The author provides an update in
    recent investment activity among the pharmaceutical majors in biologic-drug substance, vaccine, and parenteral drug
    manufacturing.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812582/pst0513_bio_t_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812582null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Applying-Continuous-Flow-Pasteurization-and-Steril/ArticleStandard/Article/detail/812590?ref=25">

    <title>Applying Continuous-Flow Pasteurization and Sterilization Processes</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Applying-Continuous-Flow-Pasteurization-and-Steril/ArticleStandard/Article/detail/812590?ref=25</link>

    <description>High-temperature, short-time (HTST) pasteurization and ultra-high temperature (UHT) sterilization are
    potentially useful as part of the trend toward methods of continuous manufacturing of
    bio/pharmaceuticals.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812590null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Drug+Delivery/Advancing-Drug-Delivery-for-Parenteral-Application/ArticleStandard/Article/detail/812592?ref=25">

    <title>Advancing Drug Delivery for Parenteral Applications</title>

    <link>
    http://www.pharmtech.com/pharmtech/Drug+Delivery/Advancing-Drug-Delivery-for-Parenteral-Application/ArticleStandard/Article/detail/812592?ref=25</link>

    <description>Researchers recently developed a drug-delivery system to mitigate problems associated with
    jet-injection drug delivery, and also improved on the design and operation of microscale actuators as a possible
    drug-delivery method.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812592null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/An-Integrated-Prefilled-Syringe-Platform-Approach-/ArticleStandard/Article/detail/812737?ref=25">

    <title>An Integrated Prefilled Syringe Platform Approach for Vaccine Development</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/An-Integrated-Prefilled-Syringe-Platform-Approach-/ArticleStandard/Article/detail/812737?ref=25</link>

    <description>The authors describe a holistic and integrated approach to focus on the linkage of the prefilled
    syringe with the four phases of product design, development, operation, and control.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812737/pts0513_vaccine_t_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812737null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Feature+Articles/Containment-Verification-Testing-For-Pharmaceutica/ArticleStandard/Article/detail/812735?ref=25">

    <title>Containment-Verification Testing For Pharmaceutical Equipment Performance</title>

    <link>
    http://www.pharmtech.com/pharmtech/Feature+Articles/Containment-Verification-Testing-For-Pharmaceutica/ArticleStandard/Article/detail/812735?ref=25</link>

    <description>A Good Practice Guide from the International Society of Pharmaceutical Engineering provides a
    framework to assess how well pharmaceutical equipment contains hazardous APIs.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812735/PTs0515_contain_t_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/192013/812735null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Online+Only/PerkinElmer-Announces-Collaboration-with-Chinas-Na/ArticleStandard/Article/detail/811913?ref=25">

    <title>PerkinElmer Announces Collaboration with China's National Center for Drug Screening</title>

    <link>
    http://www.pharmtech.com/pharmtech/Online+Only/PerkinElmer-Announces-Collaboration-with-Chinas-Na/ArticleStandard/Article/detail/811913?ref=25</link>

    <description>A personalized drug research and development platform will validate biomarkers for individualized
    disease treatment for Chinese patients.</description>

    <dc:date>2013-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811913null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Whitepapers/Protein-Separation-with-pH-Gradients-Using-Composi/ArticleStandard/Article/detail/811991?ref=25">

    <title>Protein Separation with pH Gradients Using Composite Buffer Systems</title>

    <link>
    http://www.pharmtech.com/pharmtech/Whitepapers/Protein-Separation-with-pH-Gradients-Using-Composi/ArticleStandard/Article/detail/811991?ref=25</link>

    <description>Tips and tricks on how to correctly apply the Agilent Buffer Advisor Software for the generation of pH
    gradients over a wide range using composite buffer systems.</description>

    <dc:date>2013-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/biopharm/182013/811991null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/Malvern-Instruments-and-Netzsch-Grinding-amp-Dispe/ArticleStandard/Article/detail/811914?ref=25">

    <title>Malvern Instruments and Netzsch Grinding &amp;amp;amp; Dispersing Sign Agreement to Cooperate</title>

    <link>
    http://www.pharmtech.com/pharmtech/Company+and+People+Notes/Malvern-Instruments-and-Netzsch-Grinding-amp-Dispe/ArticleStandard/Article/detail/811914?ref=25</link>

    <description>Marketing agreement involves particle-sizing and milling equipment.</description>

    <dc:date>2013-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811914null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Bayer-to-Acquire-Conceptus-for-US11-Billion/ArticleStandard/Article/detail/812030?ref=25">

    <title>Bayer to Acquire Conceptus for US$1.1 Billion</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Bayer-to-Acquire-Conceptus-for-US11-Billion/ArticleStandard/Article/detail/812030?ref=25</link>

    <description>Bayer announced that it has signed a merger agreement with US-based birth-control specialist
    Conceptus.</description>

    <dc:date>2013-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/812030null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Company+and+People+Notes/Uhlmann-Group-Spins-Off-visiotec-GmbH/ArticleStandard/Article/detail/811915?ref=25">

    <title>Uhlmann Group Spins Off visiotec GmbH</title>

    <link>
    http://www.pharmtech.com/pharmtech/Company+and+People+Notes/Uhlmann-Group-Spins-Off-visiotec-GmbH/ArticleStandard/Article/detail/811915?ref=25</link>

    <description>New company will focus on inspection, monitoring, and control systems for automated pharmaceutical
    manufacturing processes.</description>

    <dc:date>2013-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811915null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Matrikon---OPC-The-Ins-and-Outs-to-What-Its-About/ArticleStandard/Article/detail/811823?ref=25">

    <title>Matrikon - OPC: The Ins and Outs to What It's About</title>

    <link>
    http://www.pharmtech.com/pharmtech/Matrikon---OPC-The-Ins-and-Outs-to-What-Its-About/ArticleStandard/Article/detail/811823?ref=25</link>

    <description>Matrikon - OPC: The Ins and Outs to What It's About</description>

    <dc:date>2013-04-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182013/811823null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Metrics---USING-QUALITY-BY-DESIGN-TO-IMPROVE-STREN/ArticleStandard/Article/detail/811688?ref=25">

    <title>Metrics - USING QUALITY BY DESIGN TO IMPROVE STRENGTH, FRIABILITY</title>

    <link>
    http://www.pharmtech.com/pharmtech/Metrics---USING-QUALITY-BY-DESIGN-TO-IMPROVE-STREN/ArticleStandard/Article/detail/811688?ref=25</link>

    <description>Metrics - USING QUALITY BY DESIGN TO IMPROVE STRENGTH, FRIABILITY</description>

    <dc:date>2013-04-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811688null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Catalent-Biologics-Opens-New-Single-Use-Biomanufac/ArticleStandard/Article/detail/811649?ref=25">

    <title>Catalent Biologics Opens New Single-Use Biomanufacturing Facility in Madison</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Catalent-Biologics-Opens-New-Single-Use-Biomanufac/ArticleStandard/Article/detail/811649?ref=25</link>

    <description>Catalent Pharma Solutions, a provider of drug and biologic development services, delivery technologies
    and supply solutions, has officially opened a new biomanufacturing center of excellence in Madison. The facility,
    which was constructed in response to customer demand, is expected to quadruple Catalent's current biologics
    manufacturing capacity and extensively utilise single-use technology for greater flexibility and efficiency. It
    will allow the company to extend its offerings in the biologics sector while enhancing the efficiency and output of
    its proprietary GPEx cell line engineering technology as well as other mammalian cell lines.</description>

    <dc:date>2013-04-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811649null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/News/Pharmaceutical-Technology-and-DampB-Launch-Busines/ArticleStandard/Article/detail/811687?ref=25">

    <title>Pharmaceutical Technology and D&amp;amp;amp;B Launch Business Marketplace</title>

    <link>
    http://www.pharmtech.com/pharmtech/News/Pharmaceutical-Technology-and-DampB-Launch-Busines/ArticleStandard/Article/detail/811687?ref=25</link>

    <description>Pharmaceutical Technology has joined with Dun &amp;amp;amp; Bradstreet Credibility Corp. to launch the
    Pharmaceutical Technology and BioPharm International Marketplace.</description>

    <dc:date>2013-04-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811687null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Analytics/Is-My-Method-Still-Valid/ArticleStandard/Article/detail/811595?ref=25">

    <title>Is My Method (Still) Valid?</title>

    <link>
    http://www.pharmtech.com/pharmtech/Analytics/Is-My-Method-Still-Valid/ArticleStandard/Article/detail/811595?ref=25</link>

    <description>This paper outlines the importance of method validation including the official requirements,
    characteristics to be validated and minimum requirements, helping to ensure that the data generated are
    reliable.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811595null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Manufacturing+Whitepaper/Impact-of-a-Customized-MALDI-TOF-Library-for-Micro/ArticleStandard/Article/detail/811596?ref=25">

    <title>Impact of a Customized MALDI-TOF Library for Microbial Identifications</title>

    <link>
    http://www.pharmtech.com/pharmtech/Manufacturing+Whitepaper/Impact-of-a-Customized-MALDI-TOF-Library-for-Micro/ArticleStandard/Article/detail/811596?ref=25</link>

    <description>This study assesses the suitability of the Biotyper platform for identifying environmental isolates,
    demonstrates our systematic approach to broaden the reference library and shows the impact of adding new library
    entries on reportability for this industrial sector.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811596null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Standards+%26+Regulation/Establishing-a-Culture-of-Quality/ArticleStandard/Article/detail/811594?ref=25">

    <title>Establishing a Culture of Quality</title>

    <link>
    http://www.pharmtech.com/pharmtech/Standards+%26+Regulation/Establishing-a-Culture-of-Quality/ArticleStandard/Article/detail/811594?ref=25</link>

    <description>For companies seeking to prevent or remediate regulatory compliance violations, establishing a culture
    of quality is of the essence. In industries strongly affected by regulatory compliance, product quality is
    inextricably linked to a company?s well-being. Learn more about cultivating and nourishing a culture of quality in
    your firm.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811594null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Biological-Storage-Facility/ArticleStandard/Article/detail/811196?ref=25">

    <title>Biological Storage Facility</title>

    <link>
    http://www.pharmtech.com/pharmtech/Biological-Storage-Facility/ArticleStandard/Article/detail/811196?ref=25</link>

    <description>Vindon?s UK storage suite based in Rochdale offers 2000 cubic meters of controlled environment storage
    space.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811196null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Waters-Purification-Solutions/ArticleStandard/Article/detail/811198?ref=25">

    <title>Waters Purification Solutions</title>

    <link>
    http://www.pharmtech.com/pharmtech/Waters-Purification-Solutions/ArticleStandard/Article/detail/811198?ref=25</link>

    <description>Waters' robust purification solutions are flexible, scalable, and easily integrated.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811198null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/Vetter-Development-Service-Filling-your-clinical-d/ArticleStandard/Article/detail/811190?ref=25">

    <title>Vetter Development Service: Filling your clinical development needs</title>

    <link>
    http://www.pharmtech.com/pharmtech/Vetter-Development-Service-Filling-your-clinical-d/ArticleStandard/Article/detail/811190?ref=25</link>

    <description>Vetter Development Service (VDS) provides expert support for your drug-development projects, from
    inception to market launch</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811190null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.pharmtech.com/pharmtech/The-Daikyo-Crystal-Zenith-Insert-Needle-Syringe-Sy/ArticleStandard/Article/detail/811197?ref=25">

    <title>The Daikyo Crystal Zenith Insert Needle Syringe System</title>

    <link>
    http://www.pharmtech.com/pharmtech/The-Daikyo-Crystal-Zenith-Insert-Needle-Syringe-Sy/ArticleStandard/Article/detail/811197?ref=25</link>

    <description>Protect your drug product?s integrity with the industry?s first adhesive- and tungsten-free insert
    needle syringe system, the Daikyo Crystal Zenith Insert Needle Syringe System.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/172013/811197null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


